A Pilot Study of the Effect of Continuous Subcutaneous Insulin Infusion in Adolescents With Newly-Diagnosed Type 1 Diabetes on Insulin Resistance, Beta-Cell Function and the Honeymoon Period.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Insulin; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 14 Jun 2016 Biomarkers information updated
- 26 Oct 2012 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
- 26 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.